Brief: TELA Bio Q3 Revenue USD 18.957 Million Vs. IBES Estimate USD 18.9 Million
07/11/2024 21:05
Nov 07 (Reuters) - TELA Bio Q3 income from operations USD -9.365 million. * Q3 net income USD -10.372 million * Q3 operating expenses USD 22.223 million * Q3 basic EPS USD -0.42 * Q3 gross profit USD 12.858 million * outlook FY revenue USD 74.5-76.5 million
Recent news on TELA Bio
See all newsBrief: Tela Bio - Receives FDA 510(K) Clearance For Liora Monofilament Scaffold For Soft Tissue Reinforcement
Tela Bio Inc Reports Results For The Quarter Ended June 30: Earnings Summary
TELA Bio Q2 revenue falls on lower OviTex PRS volumes, withdraws outlook
Brief: TELA Bio Q2 Revenue USD 19.291 Million Vs. IBES Estimate USD 20 Million
Tela Bio Inc Expected To Post A Loss Of 18 Cents A Share: Earnings Preview